首页> 外文期刊>Biocybernetics and biomedical engineering >Continuous blood glucose level prediction of Type 1 Diabetes based on Artificial Neural Network
【24h】

Continuous blood glucose level prediction of Type 1 Diabetes based on Artificial Neural Network

机译:基于人工神经网络的1型糖尿病连续血糖水平预测

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent technological advancements in diabetes technologies, such as Continuous Glucose Monitoring (CGM) systems, provide reliable sources to blood glucose data. Following its development, a new challenging area in the field of artificial intelligence has been opened and an accurate prediction method of blood glucose levels has been targeted by scientific researchers. This article proposes a new method based on Artificial Neural Networks (ANN) for blood glucose level prediction of Type 1 Diabetes (T1D) using only CGM data as inputs. To show the efficiency of our method and to validate our ANN, real CGM data of 13 patients were investigated. The accuracy of the strategy is discussed based on some statistical criteria such as the Root Mean Square Error (RMSE) and the Mean Absolute Percentage Error (MAPE). The obtained averages of RMSE are 6.43 mg/dL, 7.45 mg/dL, 8.13 mg/dL and 9.03 mg/dL for Prediction Horizon (PH) respectively 15 min, 30 min, 45 min and 60 min and the average of MAPE was 3.87% for PH = 15 min, knowing that the smaller is the RMSE and MAPE, the more accurate is the prediction. Experimental results show that the proposed ANN is accurate, adaptive, and very encouraging for a clinical implementation. Furthermore, while other studies have only focused on the prediction accuracy of blood glucose, this work aims to improve the quality of life of T1D patients by using only CGM data as inputs and by limiting human intervention. (C) 2018 Nalecz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.
机译:糖尿病技术最近的技术进步,如连续葡萄糖监测(CGM)系统,为血糖数据提供可靠的来源。在发展之后,已经开通了人工智能领域的新具有挑战性地区,并通过科学研究人员针对了血糖水平的准确预测方法。本文提出了一种基于人工神经网络(ANN)的新方法,用于仅使用CGM数据作为输入的1型糖尿病(T1D)的血糖水平预测。为了展示我们的方法的效率和验证我们的ANN,研究了13名患者的真实CGM数据。基于一些统计标准(如根均方误差(RMSE)和平均绝对百分比误差(MAPE),讨论了策略的准确性。 RMSE的获得平均值为6.43mg / dl,7.45mg / dl,8.13mg / dl和9.03mg / dl,分别为15分钟,30分钟,45分钟和60分钟,mape的平均值为3.87 PH = 15分钟的%,知道RMSE和MAPE越小,预测越准确。实验结果表明,拟议的ANN是准确的,适应性,非常令人鼓舞的临床实施。此外,虽然其他研究仅重点关注血糖的预测准确性,但是通过仅使用CGM数据作为输入来提高T1D患者的生活质量,并通过限制人为干预。 (c)2018年纳雷斯州博士生物庭院研究所和波兰科学院的生物医学工程。 elsevier b.v出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号